Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Eisenbarth, G.S. & Lafferty, K. Type 1 diabetes: Cellular, Molecular and Clinical Immunology. Avaliable from http://www.uchsc.edu/misc/diabetes/books.html (2015).
2. Naserke, H. E., Ziegler, A. G., Lampasona, V. & Bonifacio, E. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol. 161, 6963–6969 (1998).
3. Herold, K. C. et al. Immune Tolerance Network ITN007AI Study Group. Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years. Clin Immunol. 132, 166–173 (2009).
4. Wenzlau, J. M. et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 104, 17040–5 (2007).
5. Achenbach, P. et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia. 52, 1881–1888 (2009).
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献